Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma (Annals of Surgical Oncology, (2023), 30, 12, (6953-6957), 10.1245/s10434-023-14133-8)

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original online version of this article, Merrick I. Ross's disclosure was incorrect. The original article was corrected.

Original languageEnglish (US)
Pages (from-to)7688
Number of pages1
JournalAnnals of surgical oncology
Volume30
Issue number12
DOIs
StatePublished - Nov 2023

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma (Annals of Surgical Oncology, (2023), 30, 12, (6953-6957), 10.1245/s10434-023-14133-8)'. Together they form a unique fingerprint.

Cite this